


<PAGE>
		    SECURITIES AND EXCHANGE COMMISSION
			  WASHINGTON, D.C. 20549


				 FORM 10-Q


		QUARTERLY REPORT UNDER SECTION 13 or 15(d)
		  OF THE SECURITIES EXCHANGE ACT OF 1934


For Quarter Ended  September 30, 1995      Commission File Number  1-1687 


			    PPG INDUSTRIES, INC.                            
	  (Exact name of registrant as specified in its charter)


	Pennsylvania                                         25-0730780    
(State or other jurisdiction of                          (I.R.S. Employer
 incorporation or organization)                         Identification No.)



One PPG Place, Pittsburgh, Pennsylvania                            15272   
(Address of principal executive offices)                         (Zip Code)




Registrant's telephone number, including area code      (412) 434-3131     



As of November 3, 1995, 196,044,279 shares of the Registrant's common stock, 
par value $1.66-2/3 per share, were outstanding.

Indicate by check mark whether the Registrant (1) has filed all reports 
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 
1934 during the preceding 12 months, and (2) has been subject to such filing 
requirements for the past 90 days.


		    Yes   X                 No      
<PAGE>







			   PPG INDUSTRIES, INC.
		       AND CONSOLIDATED SUBSIDIARIES
		       =============================


				   Index


Part I.  Financial Information                                        Page(s)


  Item 1.  Financial Statements:

    Condensed Statement of Income....................................       2

    Condensed Balance Sheet..........................................       3

    Condensed Statement of Cash Flows................................       4

    Notes to Condensed Financial Statements..........................   5 - 7

  Item 2.  Management's Discussion and Analysis of Financial
	   Condition and Results of Operations.......................  8 - 12


Part II.  Other Information


  Item 6.  Exhibits and Reports on Form 8-K..........................      13


Signature............................................................      14


















				    - 1 -
<PAGE>



		      Part I.  FINANCIAL INFORMATION

Item 1.  Financial Statements

		     PPG INDUSTRIES, INC. AND SUBSIDIARIES
<TABLE>
		    Condensed Statement of Income (Unaudited)
		      (Millions, except per share amounts)
<CAPTION>
				      Three Months            Nine Months
				    Ended September 30     Ended September 30
				     1995       1994        1995       1994
<S>                                <C>        <C>        <C>         <C>
Net sales........................  $1,724.1   $1,575.3   $5,335.3    $4,671.5
Cost of sales....................   1,029.4      962.1    3,166.8     2,861.8
  Gross profit...................     694.7      613.2    2,168.5     1,809.7

Other expenses:
  Selling, general and
    administrative...............     246.8      225.7      736.5       665.2
  Depreciation...................      83.2       78.6      246.1       236.1
  Research and development.......      59.8       55.7      176.0       159.1
  Interest.......................      21.2       21.8       62.4        66.0
  Business divestiture (Note 3)..        --         --         --        85.0
  Other charges..................      31.9       29.1      102.0        72.7

  Total other expenses...........     442.9      410.9    1,323.0     1,284.1

Other earnings...................      28.3       34.4      150.4        81.9

Income before income taxes
  and minority interest..........     280.1      236.7      995.9       607.5

Income taxes.....................     106.4       86.2      378.4       230.9

Minority interest................       3.3        5.0       11.1        13.0

Net income.......................  $  170.4   $  145.5    $ 606.4    $  363.6 

Earnings per share...............  $   0.85   $   0.68    $  2.97    $   1.71

Dividends per share..............  $   0.30   $   0.28    $  0.88    $   0.83

Average shares outstanding.......     200.9      212.5      204.0       212.7
</TABLE>






The accompanying notes to the condensed financial statements are an integral 
part of this statement.

				    - 2 -
<PAGE>




		   PPG INDUSTRIES, INC. AND SUBSIDIARIES
<TABLE>
		    Condensed Balance Sheet (Unaudited)
<CAPTION>
						 Sept. 30       Dec. 31
						   1995           1994
							(Millions)
<S>                                              <C>           <C>
Assets                                                  
Current assets:
  Cash and cash equivalents...................   $  118.3      $   62.1
  Receivables-net.............................    1,319.8       1,228.9
  Inventories (Note 2)........................      759.9         686.4
  Other.......................................      176.6         190.8
    Total current assets......................    2,374.6       2,168.2

Property (less accumulated depreciation of
  $3,629.0 million and $3,420.4 million)......    2,763.6       2,742.3
Investments...................................      201.6         277.4
Other assets..................................      848.6         706.0
    Total.....................................   $6,188.4      $5,893.9

Liabilities and Shareholders' Equity
Current liabilities:
  Short-term borrowings and current
    portion of long-term debt.................   $  444.6      $  370.7
  Accounts payable and accrued liabilities....    1,096.3       1,034.4
  Income taxes................................       39.4          19.4
    Total current liabilities.................    1,580.3       1,424.5

Long-term debt (Note 7).......................      744.5         773.4
Deferred income taxes.........................      335.0         302.7
Accumulated provisions........................      299.1         260.5
Other postretirement benefits.................      516.3         505.5
Minority interest.............................       72.2          70.3
    Total liabilities.........................    3,547.4       3,336.9

Shareholders' equity:
  Common stock (Note 8).......................      484.3         484.3
  Additional paid-in capital..................       72.4          67.5
  Retained earnings...........................    4,145.9       3,717.1
  Treasury stock..............................   (1,874.8)     (1,488.6)
  Unearned compensation.......................     (187.9)       (183.0)
  Minimum pension liability adjustment........       (3.0)         (1.7)
  Currency translation adjustment.............        4.1         (38.6)
    Total shareholders' equity................    2,641.0       2,557.0

    Total.....................................   $6,188.4      $5,893.9
</TABLE>


The accompanying notes to the condensed financial statements are an integral 
part of this statement.

				    - 3 -
<PAGE>



		   PPG INDUSTRIES, INC. AND SUBSIDIARIES
<TABLE>
	       Condensed Statement of Cash Flows (Unaudited)
<CAPTION>
						 Nine Months Ended Sept. 30
						    1995            1994
							 (Millions)
<S>                                                <C>             <C>
Cash from operating activities...............      $ 731.6         $ 503.0

Investing activities:
   Capital spending..........................       (284.2)         (224.0)
   Reduction of investments..................        129.1            28.5
   Other.....................................         22.8            54.8
	Cash used for investing activities...       (132.3)         (140.7)

Financing activities:
   Net change in borrowings with
     maturities of three months or less......        (30.6)          (74.4)
   Proceeds from other short-term debt.......         38.6            31.0
   Repayment of other short-term debt........        (55.8)          (23.9)
   Proceeds from long-term debt..............        118.3            10.3
   Repayment of long-term debt...............        (40.3)          (28.7)
   Loans to employee stock ownership plan....        (25.0)          (11.0)
   Repayment of loans by employee stock
     ownership plan..........................         20.1            14.8
   Purchase of treasury stock, net...........       (388.3)          (53.0)
   Dividends paid............................       (180.1)         (176.4)
	Cash used for financing activities...       (543.1)         (311.3)

Effect of currency exchange rate changes
  on cash and cash equivalents...............           --             2.8

Net increase in cash and
  cash equivalents...........................         56.2            53.8

Cash and cash equivalents,
  beginning of period........................         62.1           111.9

Cash and cash equivalents,
  end of period..............................      $ 118.3         $ 165.7
</TABLE>









The accompanying notes to the condensed financial statements are an integral 
part of this statement.

				    - 4 -
<PAGE>



		   PPG INDUSTRIES, INC. AND SUBSIDIARIES

	    Notes to Condensed Financial Statements (Unaudited)


1.   Financial Statements

	The condensed financial statements included herein are unaudited.  In 
the opinion of management, these statements include all adjustments, 
consisting only of normal, recurring adjustments, necessary for a fair 
presentation of the financial position of PPG Industries, Inc. and 
consolidated subsidiaries (the Company or PPG) at September 30, 1995, 
and the results of their operations for the three- and nine-month 
periods ended September 30, 1995 and 1994 and their cash flows for the 
nine-month periods ended September 30, 1995 and 1994.  These condensed 
financial statements should be read in conjunction with the financial 
statements and notes thereto incorporated by reference in PPG's Annual 
Report on Form 10-K for the year ended December 31, 1994.

	The results of operations for the nine months ended September 30, 1995 
are not necessarily indicative of the results to be expected for the 
full year.


2.   Inventories

	Inventories at September 30, 1995, and December 31, 1994, are detailed 
below.
<TABLE>
<CAPTION>
							Sept. 30    Dec. 31
							  1995        1994
							     (Millions)
      <S>                                                <C>         <C>
      Finished products and work in process............  $507.8      $462.7
      Raw materials....................................   138.9       111.9
      Supplies.........................................   113.2       111.8

	Total..........................................  $759.9      $686.4
</TABLE>
	Most domestic and certain foreign inventories are valued using the last-
in, first-out method.  If the first-in, first-out method had been used, 
inventories would have been $211.3 million and $199.2 million higher at 
September 30, 1995 and December 31, 1994, respectively.


3.   Business Divestiture

PPG's operating results reflect the impact of the Company's programs to 
divest businesses and activities not meeting strategic or performance 
objectives.  The 1994 charge pertains to the divestiture of the 
Biomedical Systems Division.  Refer to Management's Discussion and 
Analysis of Financial Condition and Results of Operations for further 
details regarding this charge.

				    - 5 -
<PAGE>



4.   Cash Flow Information

	Cash payments for interest for the nine months ended September 30, 1995 
and 1994 were $61.0 million and $63.7 million, respectively.  Cash 
payments for income taxes for the nine months ended September 30, 1995 
and 1994 were $279.4 million and $217.4 million, respectively.


5.   Business Segment Information
<TABLE>
<CAPTION>
				   Three Months            Nine Months
				Ended September 30     Ended September 30
				  1995       1994        1995       1994
						(Millions)
     <S>                         <C>        <C>         <C>        <C>
     Net Sales:
	  Coatings and Resins..  $  669     $  640      $2,110     $1,956
	  Glass................     655        594       2,014      1,779
	  Chemicals............     400        342       1,211        937

	    Total..............  $1,724     $1,576      $5,335     $4,672

     Operating Income (Loss):
	  Coatings and Resins..  $   91     $  109      $  363     $  376
	  Glass................     114         74         404        243
	  Chemicals............      90         68         286        139
	  Other (1)............      --         --          --        (85)
	    Total operating
	     income............     295        251       1,053        673

     Interest expense - net....     (18)       (19)        (54)       (59)

      Other unallocated 
	corporate income
	(expense) - net........       3          5          (3)        (6)

      Income before income 
      taxes and minority 
      interest.................  $  280     $  237      $  996     $  608
</TABLE>
	  (1)   Loss in 1994 represents the charge to divest the Biomedical 
Systems Division (see Note 3).


6.   Environmental Matters

Management of the Company anticipates that the resolution of the 
environmental contingencies discussed below, which will occur over an 
extended period of time, will not result in future annual charges to 
income that are significantly greater than those recorded in recent 
years.  It is possible, however, that technological, regulatory and 
enforcement developments, the results of environmental studies and other 
factors could alter this expectation.  In management's opinion, the 
	 

				      - 6 -
<PAGE>

Company operates in an environmentally sound manner and the outcome of 
these environmental matters will not have a material effect on PPG's 
financial position or liquidity.  To date, compliance with federal, 
state and local requirements has not had a material impact on PPG's 
financial position, results of operations or liquidity.

It is PPG's policy to accrue expenses for environmental contingencies 
when it is probable that a liability exists and the amount of loss can 
be reasonably estimated.  As of September 30, 1995 and December 31, 
1994, PPG had environmental reserves totaling $97 million and 
$90 million, respectively.  Charges against income for environmental 
remediation costs for the nine-month periods ended September 30, 1995 
and 1994 were $35 million and $25 million, respectively.

In addition to the amounts accrued, the Company may be subject to 
contingencies related to environmental matters estimated at the high end 
to be as much as $200 million to $400 million.  Such aggregate losses 
are reasonably possible but not currently considered to be probable of 
occurrence.  The Company's current environmental contingencies are 
expected to be resolved over a period of 20 years or more.  These loss 
contingencies include significant unresolved issues such as the nature 
and extent of contamination, if any, at sites and the methods that may 
have to be employed should remediation be required.  Although insurance 
may cover a portion of these costs, to the extent they are incurred, any 
potential recovery is not included in this unrecorded exposure to future 
loss.  With respect to certain waste sites, the financial condition of 
any other potentially responsible parties also contributes to the 
uncertainty of estimating PPG's final costs.  Although contributors of 
waste to sites involving other potentially responsible parties may face 
governmental agency assertions of joint and several liability, in 
general, final allocations of costs are made based on the relative 
contributions of wastes to such sites.  PPG is generally not a major 
contributor to such sites.  Although the unrecorded exposure to future 
loss relates to all sites, a significant portion of such unrecorded 
exposure involves three operating plant sites and one closed plant site. 
Two of the sites are in the early stages of study, while the remaining 
two are further into the study phase.  All four sites require additional 
study to assess the magnitude of contamination, if any, and the 
remediation alternatives.


7.   Long-term Debt

On August 3, 1995, the Company issued $100 million of non-callable 
6 7/8% notes which are due August 1, 2005.


8.   Common Stock

On April 20, 1995, the Company's Restated Articles of Incorporation were 
amended to increase the number of authorized shares of common stock from 
300 million to 600 million.


				    - 7 -
<PAGE>


Item 2.  Management's Discussion and Analysis of Financial
	 Condition and Results of Operations

Performance in the Third Quarter of 1995 Compared with the Third Quarter of 
1994

Performance Overview

Sales for the third quarter of 1995 and 1994 were $1.72 billion and $1.58 
billion, respectively.  The sales increase was primarily attributable to 
higher prices in virtually all product lines, particularly for our chlor-
alkali and derivative, fiber glass, and flat glass products.  Also 
contributing to the sales increase were higher volumes, particularly in our 
European operations, and the favorable effects of foreign currency 
translation.

The gross profit percentage increased to 40.3% from 38.9% in the prior year's 
quarter primarily due to higher sales prices in all business segments.  The 
negative effects of inflation partially offset these gains.

Net income and earnings per share for the 1995 quarter were $170.4 million and 
$0.85, respectively.  In the third quarter of 1994, net income and earnings 
per share were $145.5 million and $0.68, respectively.  Current period net 
income was favorably impacted by the factors that contributed to the gross 
profit percentage improvement and higher sales volumes.  Partially offsetting 
these gains were increased overhead costs, higher income tax expense, and 
lower other earnings.

Performance of Business Segments

Coatings and resins sales increased to $669 million from $640 million in the 
third quarter of 1994.  Operating income for the corresponding periods were 
$91 million and $109 million, respectively.  The increase in sales was 
primarily attributable to stronger pricing in all product lines, higher 
volumes for our European automotive original products, and the favorable 
effects of translating European currencies.  The effects of lower volumes for 
most of our North American product lines partially offset these improvements.  
Despite higher sales, operating income declined as the favorable effects of 
price improvements were more than offset by the negative impact of inflation, 
particularly on raw material costs.

Glass sales increased to $655 million in the third quarter of 1995 from $594 
million in the prior year's quarter.  Operating income increased to $114 
million from $74 million in the corresponding 1994 period.  Contributing to 
the sales increase were higher sales prices, principally for worldwide fiber 
glass and flat glass products and North American automotive replacement glass, 
higher volumes, particularly for our North American automotive original glass 
products, and the favorable effects of translating European currencies.  The 
effect of lower North American automotive replacement glass volume partially 
offset these improvements.  Increased operating income was primarily the 
result of the factors that contributed to the sales increase, partially offset 
by the negative effects of inflation and higher overhead costs.


				    - 8 -
<PAGE>



Chemicals sales increased to $400 million from $342 million in the third 
quarter of 1994.  Operating income for the corresponding periods was $90 
million and $68 million, respectively.  The increase in sales was primarily 
attributable to substantial price increases for chlor-alkali and derivative 
products and higher volumes for Transitions (registered trademark) optical 
lenses.  These improvements were partially offset by the effect of lower 
volumes for our chlor-alkali and derivative products.  The increase in 
operating income was attributable to the factors that contributed to the sales 
increase, partially offset by increases in other charges, net of other 
earnings, and overhead costs.  The increase in other charges, net of other 
earnings, was the result of a non-recurring freight charge, the absence of the 
1994 third quarter gain from the disposition of the segment's polymer 
additives business, and higher environmental expense.

The "other" segment's 1994 operating loss represents the charge to divest the 
Biomedical Systems Division.

Performance in the First Nine Months of 1995 Compared with the First Nine 
Months of 1994

Performance Overview

Sales for the first nine months of 1995 and 1994 were $5.34 billion and $4.67 
billion, respectively.  The sales increase was attributable to higher prices 
in most product lines, particularly for our chlor-alkali and derivative, fiber 
glass, and flat glass products, higher volumes in each of the business 
segments, and the favorable effects of foreign currency translation.

The gross profit percentage increased to 40.6% from 38.7% in the prior year 
period primarily due to higher sales prices in all business segments.  The 
negative effects of inflation partially offset these gains.

Net income and earnings per share for the current year period were $606.4 
million and $2.97, respectively, which included a $24.2 million after-tax gain 
($0.12 per share) from a legal settlement of a glass technology dispute with 
Pilkington plc of England.  In the prior year period, net income and earnings 
per share were $363.6 million and $1.71, respectively, including a $51.9 
million ($0.24 per share) second quarter after-tax charge to divest the 
Biomedical Systems Division.  Current period earnings were favorably impacted 
by the factors that contributed to the gross profit percentage improvement, 
the absence of the business divestiture charge, higher sales volumes, and 
increased other earnings which were attributable to several gains from legal 
settlements and higher earnings from our equity affiliates.  Partially 
offsetting these items were higher income tax expense and increased other 
charges.  The majority of the increase in other charges was the result of a 
charge for a legal dispute and higher environmental expense.

Performance of Business Segments

Coatings and resins sales increased to $2.11 billion in the first nine months 
of 1995 from $1.96 billion in the prior year period.  Operating income for the 
corresponding periods was $363 million and $376 million, respectively.

				    - 9 -
<PAGE>

Contributing to the sales increase were higher volumes in most European 
product lines, particularly automotive original products, the favorable 
effects of translating European currencies, and stronger prices, primarily in 
our automotive refinish products.  The effect of lower North American 
automotive refinish volume partially offset these improvements.  Operating 
income declined as the negative effects of inflation, particularly on raw 
material costs, were only partially offset by increased volumes, higher 
prices, and gains from legal settlements.

Glass sales increased to $2.01 billion in the nine-month period ended 
September 30, 1995, from $1.78 billion in the prior year period.  Operating 
income increased to $404 million from $243 million in the corresponding 1994 
period. Contributing to the sales increase were higher sales prices, 
principally for worldwide fiber glass and flat glass products and North 
American automotive replacement glass, higher volumes in most of the segment's 
major businesses, principally worldwide fiber glass and automotive original 
glass products, and the favorable effects of translating European currencies.  
The effect of lower volume in North American automotive replacement glass 
partially offset these improvements.  Increased operating income was primarily 
the result of the factors that contributed to the sales increase and the gain 
from the first quarter legal settlement with Pilkington.  The negative effects 
of inflation and higher overhead costs partially offset these improvements.

Chemicals sales increased to $1.21 billion for the nine-month period ended 
September 30, 1995 from $937 million in the corresponding prior period.  
Operating income increased to $286 million from $139 million for the first 
nine months of 1994.  The increase in sales was primarily attributable to 
substantial price gains for chlor-alkali and derivative products and volume 
improvements for specialty products, particularly Transitions (registered 
trademark) optical lenses.  The increase in operating income was attributable 
to the factors that contributed to the sales increase.  Partially offsetting 
these improvements were the negative effects of inflation, particularly on 
ethylene costs, increased other charges, the majority of which related to a 
charge for a legal dispute, increased environmental expenses, and a non-
recurring freight charge, as well as higher overhead costs.

The "other" segment's 1994 operating loss represents the charge to divest the 
Biomedical Systems Division.

Other Factors

Higher inventories were mainly due to a build-up in our coatings and resins 
segment, primarily in Europe, to support stronger sales volumes.  Also 
contributing to the increase was the strengthening of certain European 
currencies against the U.S. dollar.

The decline in investments was principally due to a loan taken against the 
cash surrender value of an investment in company-owned life insurance.

Pension plan contributions were the main factors contributing to the increase 
in other assets.



				    - 10 -
<PAGE>
The increase in short-term debt and current portion of long-term debt was due 
to a reclassification of the portion of long-term notes maturing in the first 
nine months of 1996 to current liabilities, partially offset by the repayment 
of certain short-term borrowings with cash generated from operations.  The 
corresponding decline in long-term debt was partially offset by the issuance 
of $100 million of non-callable 6 7/8% notes in August 1995.

The ten million share repurchase program approved by PPG's Board of Directors 
in April 1995 has been completed.  PPG's Board of Directors approved an 
additional repurchase of ten million shares of PPG common stock in October 
1995.  The shares may be repurchased in open market or private transactions 
and a timetable for this additional repurchase program has not been 
established.

On November 8, 1995 the Company intends to file a Registration Statement on 
Form S-3 to cover offerings in the future of up to $500 million aggregate 
principal amount of debt securities.  Such debt securities would be offered on 
terms to be determined at the time of the offering.  The proceeds from the 
sale of such debt securities would be added to the Company's general funds and 
be used for general corporate purposes or for such purposes as may be 
disclosed at the time any debt is issued.

Environmental Matters

Management of the Company anticipates that the resolution of the environmental 
contingencies discussed below, which will occur over an extended period of 
time, will not result in future annual charges to income that are 
significantly greater than those recorded in recent years.  It is possible, 
however, that technological, regulatory and enforcement developments, the 
results of environmental studies and other factors could alter this 
expectation.  In management's opinion, the Company operates in an 
environmentally sound manner and the outcome of these environmental matters 
will not have a material effect on PPG's financial position or liquidity.  To 
date, compliance with federal, state and local requirements has not had a 
material impact on PPG's financial position, results of operations or 
liquidity.

It is PPG's policy to accrue expenses for environmental contingencies when it 
is probable that a liability exists and the amount of loss can be reasonably 
estimated.  As of September 30, 1995 and December 31, 1994, PPG had 
environmental reserves totaling $97 million and $90 million, respectively.  
Charges against income for environmental remediation costs for the nine-month 
periods ended September 30, 1995 and 1994 were $35 million and $25 million, 
respectively.

In addition to the amounts accrued, the Company may be subject to 
contingencies related to environmental matters estimated at the high end to be 
as much as $200 million to $400 million.  Such aggregate losses are reasonably 
possible but not currently considered to be probable of occurrence.  The 
Company's current environmental contingencies are expected to be resolved over 
a period of 20 years or more.  These loss contingencies include significant 
unresolved issues such as the nature and extent of contamination, if any, at 
sites and the methods that may have to be employed should remediation be 
required.  Although insurance may cover a portion of these costs, to the 
      
				    - 11 -
<PAGE>
extent they are incurred, any potential recovery is not included in this 
unrecorded exposure to future loss.  With respect to certain waste sites, the 
financial condition of any other potentially responsible parties also 
contributes to the uncertainty of estimating PPG's final costs.  Although 
contributors of waste to sites involving other potentially responsible parties 
may face governmental agency assertions of joint and several liability, in 
general, final allocations of costs are made based on the relative 
contributions of wastes to such sites.  PPG is generally not a major 
contributor to such sites.  Although the unrecorded exposure to future loss 
relates to all sites, a significant portion of such unrecorded exposure 
involves three operating plant sites and one closed plant site. Two of the 
sites are in the early stages of study, while the remaining two are further 
into the study phase.  All four sites require additional study to assess the 
magnitude of contamination, if any, and the remediation alternatives.

Business Divestiture

PPG's operating results reflect the impact of the Company's programs to divest 
businesses and activities not meeting strategic or performance objectives.  
The 1994 charge pertains to the divestiture of the Biomedicals System 
Division.  The majority of the charge was comprised of the reversal of a $60 
million gain originally anticipated from divestiture of the division's sensors 
business at the time the decision was made to dispose of the division and 
reflects the general decline in health-care and related markets.  Also, a $13 
million charge was taken for additional operating losses anticipated because 
of extension of the expected disposal date as well as actual operating losses 
exceeding those originally estimated.  With the sale of the sensors business 
in January 1995, the divestiture of the Biomedical Systems Division is 
complete.

Foreign Currency and Interest Rate Risk

As a multinational company, PPG manages its transaction exposure to foreign 
currency risk to minimize the volatility of cash flows caused by currency 
fluctuations.  The Company manages its foreign currency transaction exposures 
principally through the purchase of forward and option contracts.  It does not 
manage its exposure to translation gains and losses; however, by borrowing in 
local currencies it reduces such exposure.  The market value of the forward 
and option contracts purchased and outstanding as of September 30, 1995, was 
not material.

The Company manages its interest rate risk in order to balance its exposure 
between fixed and variable rates while attempting to minimize its interest 
costs.  PPG principally manages its interest rate risk by retiring and issuing 
debt from time to time.  To a limited extent, PPG manages its interest rate 
risk through the purchase of interest rate swaps.  As of September 30, 1995 
and December 31, 1994, the notional principal amounts and fair values of 
interest rate swaps held were not material.

PPG's policies do not permit active trading of currency or interest rate 
derivatives.



				    - 12 -
<PAGE>


		       Part II.  OTHER INFORMATION

Item 6.   Exhibits and Reports on Form 8-K

     (a)  Exhibits

	    (10.1) Nonqualified Retirement Plan as amended through September
		   20, 1995

	    (10.2) Supplemental Executive Retirement Plan II as amended 
		   through September 20, 1995

	    (10.3) Directors' Retirement Plan as amended through September 20,
		   1995

	    (10.4) Deferred Compensation Plan for Directors as amended through
		   September 20, 1995

	    (10.5) Change in Control Employment Agreement

	    (11)   Computation of Earnings Per Share

	    (27)   Financial Data Schedule

     (b)  Reports on Form 8-K

The Company filed a Form 8-K on August 11, 1995, dated July 31, 
1995, filing exhibits to become, by way of incorporation by 
reference, exhibits to Registration Statement No. 33-04983 on Form 
S-3.  No financial statements were filed.

The Company filed a Form 8-K on October 20, 1995, dated October 19, 
1995.  The report indicated that on October 19, 1995 the Board of 
Directors approved the repurchase of ten million shares of the 
Company's outstanding common stock, par value $1.66 2/3 per share. 
The shares may be repurchased in open market or private 
transactions and a timetable was not established for the 
repurchase.
















				    - 13 -
<PAGE>



				 SIGNATURE





Pursuant to the requirements of the Securities Exchange Act of 1934, the 
Registrant has duly caused this report to be signed on its behalf by the 
undersigned thereunto duly authorized.





						  PPG INDUSTRIES, INC.     
						      (Registrant)





Date:     November 8, 1995                     /s/ W. H. Hernandez         
						   W. H. Hernandez
					     Senior Vice President, Finance
					       (Principal Financial and
						Accounting Officer and
						Duly Authorized Officer)



























				    - 14 -
<PAGE>







		   PPG INDUSTRIES, INC. AND SUBSIDIARIES

			     INDEX TO EXHIBITS



Exhibit
  No.                  Description             

  10.1      Nonqualified Retirement Plan as amended through September 20, 1995

  10.2      Supplemental Executive Retirement Plan II as amended through
	    September 20, 1995

  10.3      Directors' Retirement Plan as amended through September 20, 1995

  10.4      Deferred Compensation Plan for Directors as amended through
	    September 20, 1995

  10.5      Change in Control Employment Agreement

  11        Computation of Earnings Per Share

  27        Financial Data Schedule


